Clinical Manual of Total Cardiovascular Risk

Name: Clinical Manual of Total Cardiovascular Risk
Brand: Springer Nature
SKU: 9781848002524
Availability: InStock

Best Price (Coupon Required):
Buy Clinical Manual of Total Cardiovascular Risk for $36.00 at @ Link.springer.com when you apply the 10% OFF coupon at checkout.
Click “Get Coupon & Buy” to copy the code and unlock the deal.

Set a price drop alert to never miss an offer.

1 Offer Price Range: $39.99 - $39.99

BEST PRICE

Single Product Purchase

$36.00

@ Link.springer.com with extra coupon

Price Comparison

Seller	Contact Seller	List Price	On Sale	Shipping	Best Promo	Final Price	Volume Discount	Financing	Availability	Seller's Page
BEST PRICE 1 Product Purchase @ Link.springer.com		$39.99	$39.99		10% OFF This deals requires coupon	$36.00		See Site	In stock	Visit Store

Product Details

Brand

Springer Nature

Manufacturer

N/A

Part Number

GTIN

9781848002524

Condition

New

Product Description

Over the last 1020 years, there has been an increasing appreciation of the need to manage individual risk factors for cardiovascular disease (CVD) in the context of overall cv risk rather than on the basis of the absolute level of any given risk factor. This approach has given rise to the misnomer global risk and gen- ated extensive lip-service around this more broad-minded approach to managing risk factors and the prevention of CVD. This short book was devised with the idea of providing a practical summary of the rationale for management based on estimated total CV risk and the various methods associated with so-doing. Practical issues are addressed including treatment thresholds and targets for the major risk factors on which we routinely intervene, and a brief descr- tion of the major means of these interventions is provided. Whilst a multifactorial approach to CV prevention is logical and reflects the pathophysiological processes which underpin the formation of athe- sclerosis, the evidence base to guide practice using estimated CV risk (global risk) as a threshold for intervention is essentially non-existent. Meanwhile, pending supportive evidence from randomized trials, prac- cal, pragmatic, and cost-effective approaches to preventing CVD, which is the current biggest contributor to global mortality and burden of disease, is urgently required. The hope is that this book may make a small contribution toward reducing the horrendous burden which CVD currently imposes on the world.

Available Colors

N/A

Available Sizes

N/A